CAS No. 862314-47-4

CHROMATE(1-),BIS[3-[[4,5-DIHYDRO-3-METHYL-5-(OXO-.KAPPA.O)-1-PHENYL-1H-PYRAZOL-4-YL]AZO-.KAPPA.N1]-4-(HYDROXY-.KAPPA.O)-N-(1-METHYLETHYL)BENZENESULFONAMIDATO(2-)]-,HYDROGEN,COMPD. WITH 2-PROPANAMINE (1:1)

5,8-Quinazolinedione, 7-chloro-6-[(4-chlorophenyl)amino]-

(z)-n-(1h-benzimidazol-2-yl)-1-methylpiperidin-2-imine

Glycine,N-[4-[[4-(2,4-dichlorophenyl)-2-[(1E)-2-[4'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]ethenyl]-1H-imidazol-1-yl]methyl]phenyl]-, methyl ester

(S)-7-Nitro-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid

9H-Purin-2-amine, 6-chloro-9-[(4-methyl-2-quinolinyl)methyl]-

848696-86-6

Pyrazolo[3,4-d]azepine,2-cyclopropyl-2,4,5,6,7,8-hexahydro-3-(4-methylphenyl)-

quino[8,7-h]quinoline

2-Pteridinamine,6-(3,4-dimethoxyphenyl)-4-[4-(3-pyridinylmethyl)-1-piperazinyl]-

1-Propanol, 3-[dimethyl(4-phenoxyphenyl)silyl]-

2'- DEOXYINOSINE- 5'- O- MONOPHOSPHOROTHIOATE ( 5'-DIMPS )

3,7-Octadien-2-one, 3,4-dimethyl-, (Z)-

3643-43-4

2-(4-nitrobenzoylamino)benzoic acid methyl ester

P11 (His-Ser-Asp-Val-His-Lys-NH2, Potent antagonist of alphavbeta3-vitronectin Interaction, Antiangiogenic)

N,N-Bis[3-(2,3-dihydroxybenzamido)propyl]-2-(2,3-dihydroxyphenyl)-5(S)-methyl-4,5-dihydrooxazole-4(R)-carboxamide

1,2,3-Butanetriol,4-[(2S,3S,4S)-3,4-dihydroxy-2-(hydroxymethyl)-1-pyrrolidinyl]-,2-(hydrogen sulfate), (2R,3S)-

7H-Pyrrolo[2,3-d]pyrimidine-5-ethanol,2-amino-4-chloro-7-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]-

1,2,3-Butanetrione, 1-phenyl-, 2-hydrazone

13339-99-6

2H-Pyran-2-one,6-cyclopentyl-6-[2-(2-ethoxy-5-ethyl-4-hydroxyphenyl)ethyl]-5,6-dihydro-4-hydroxy-3-[(6-methyl[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl]-, (6S)-

COBALTATE(1-),BIS[3-[[1-(4-CHLOROPHENYL)-4,5-DIHYDRO-3-METHYL-5-(OXO-.KAPPA.O)-1H-PYRAZOL-4-YL]AZO-.KAPPA.N1]-4-(HYDROXY-.KAPPA.O)-N-METHYLBENZENESULFONAMIDATO(2-)]-,SODIUM

Naphthalene, 2-methoxy-1-[(methylsulfinyl)(methylthio)methyl]-

L-Histidine,N-[3-[[(4S,5S)-5-[3-[[3-(1H-imidazol-1-yl)propyl]amino]-3-oxopropoxy]-1,2-dithian-4-yl]oxy]-1-oxopropyl]-, methyl ester

Ethanol, 2-methoxy-, reaction products with 3,4-dihydro-2-methoxy-2H-pyran

dodecanoic acid, compd. with 4,6-dimethyl-N-phenyl-2-pyrimidinamine (1:1)

218765-43-6

Benzoic acid, 4-[[4-(dimethylundecylsilyl)butyl]amino]-, monosodiumsalt

3-(1h-pyrazol-1-yl)-1-propanamine Dihydrochloride

(e)-1-methyl-n-(3-methylpyridin-2-yl)pyrrolidin-2-imine

2H-Pyrazolo[3,4-c]pyridine,4,5,6,7-tetrahydro-2-(1-methylethyl)-6-(phenylmethyl)-3-(3-thienyl)-

6H-Pyrrolo[2,3-d]pyrimidin-6-one,2-amino-4-chloro-7-[(4-chloro-3,5-dimethyl-1-oxido-2-pyridinyl)methyl]-5,7-dihydro-

Morpholine,4-[[3-[[(tetrahydro-2H-pyran-2-yl)oxy]methyl]-5-isoxazolyl]methyl]-

489437-88-9

Benzoic acid,4-[[4-(2,4-dichlorophenyl)-2-[(1E)-2-[4'-(1,1-dimethylethyl)[1,1'-biphenyl]-4-yl]ethenyl]-1H-imidazol-1-yl]methyl]-, methyl ester

2-methoxy-4-(prop-2-en-1-yl)phenyl 4-[(diaminomethylidene)amino]benzoate

2,2-Difluoroethyl trifluoroacetate

2-deoxy-2-[({[(Z)-[4-(dimethylamino)-6,10,11,12a-tetrahydroxy-6-methyl-1,3,12-trioxo-3,4,4a,5,5a,6,12,12a-octahydrotetracen-2(1H)-ylidene](hydroxy)methyl]amino}methyl)amino]hexopyranose dihydrochloride

1-Propanone,3-[[2-methoxy-5-(methylthio)-3-thienyl]thio]-3-(3-nitrophenyl)-1-phenyl-

Glycine,N-[4-[[4-(2,4-dichlorophenyl)-2-[(1E)-2-[4'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]ethenyl]-1H-imidazol-1-yl]methyl]phenyl]-N-[(trifluoromethyl)sulfonyl]-, methyl ester

863247-54-5